Morgan Stanley reiterates Overweight on Eli Lilly stock, $1,313 target

Morgan Stanley reiterates Overweight on Eli Lilly stock, $1,313 target

No description available.

March 27, 2026

Read Full Article
Source Information
Investing.com
Investing.com
Israel
Center